Wei Wang1, Bessie A Young, Tibor Fülöp, Ian H de Boer, L Ebony Boulware, Ronit Katz, Adolfo Correa, Michael E Griswold. 1. Center of Biostatistics and Bioinformatics (WW, MEG), University of Mississippi Medical Center, Jackson, Mississippi; Center for Innovation and Hospital and Specialty Care (BAY, IHdB, RK), Veterans Affairs Puget Sound Health Care System, Seattle, Washington; Division of Nephrology and Kidney Research Institute (BAY, IHdB), University of Washington, Seattle, Washington; Department of Medicine (TF, AC), University of Mississippi Medical Center, Jackson, Mississippi; and Department of Medicine (LEB), Duke University, Durham, North Carolina.
Abstract
BACKGROUND: The calibration to isotope dilution mass spectrometry-traceable creatinine is essential for valid use of the new Chronic Kidney Disease Epidemiology Collaboration equation to estimate the glomerular filtration rate. METHODS: For 5,210 participants in the Jackson Heart Study (JHS), serum creatinine was measured with a multipoint enzymatic spectrophotometric assay at the baseline visit (2000-2004) and remeasured using the Roche enzymatic method, traceable to isotope dilution mass spectrometry in a subset of 206 subjects. The 200 eligible samples (6 were excluded, 1 for failure of the remeasurement and 5 for outliers) were divided into 3 disjoint sets-training, validation and test-to select a calibration model, estimate true errors and assess performance of the final calibration equation. The calibration equation was applied to serum creatinine measurements of 5,210 participants to estimate glomerular filtration rate and the prevalence of chronic kidney disease (CKD). RESULTS: The selected Deming regression model provided a slope of 0.968 (95% confidence interval [CI], 0.904-1.053) and intercept of -0.0248 (95% CI, -0.0862 to 0.0366) with R value of 0.9527. Calibrated serum creatinine showed high agreement with actual measurements when applying to the unused test set (concordance correlation coefficient 0.934, 95% CI, 0.894-0.960). The baseline prevalence of CKD in the JHS (2000-2004) was 6.30% using calibrated values compared with 8.29% using noncalibrated serum creatinine with the Chronic Kidney Disease Epidemiology Collaboration equation (P < 0.001). CONCLUSIONS: A Deming regression model was chosen to optimally calibrate baseline serum creatinine measurements in the JHS, and the calibrated values provide a lower CKD prevalence estimate.
BACKGROUND: The calibration to isotope dilution mass spectrometry-traceable creatinine is essential for valid use of the new Chronic Kidney Disease Epidemiology Collaboration equation to estimate the glomerular filtration rate. METHODS: For 5,210 participants in the Jackson Heart Study (JHS), serum creatinine was measured with a multipoint enzymatic spectrophotometric assay at the baseline visit (2000-2004) and remeasured using the Roche enzymatic method, traceable to isotope dilution mass spectrometry in a subset of 206 subjects. The 200 eligible samples (6 were excluded, 1 for failure of the remeasurement and 5 for outliers) were divided into 3 disjoint sets-training, validation and test-to select a calibration model, estimate true errors and assess performance of the final calibration equation. The calibration equation was applied to serum creatinine measurements of 5,210 participants to estimate glomerular filtration rate and the prevalence of chronic kidney disease (CKD). RESULTS: The selected Deming regression model provided a slope of 0.968 (95% confidence interval [CI], 0.904-1.053) and intercept of -0.0248 (95% CI, -0.0862 to 0.0366) with R value of 0.9527. Calibrated serum creatinine showed high agreement with actual measurements when applying to the unused test set (concordance correlation coefficient 0.934, 95% CI, 0.894-0.960). The baseline prevalence of CKD in the JHS (2000-2004) was 6.30% using calibrated values compared with 8.29% using noncalibrated serum creatinine with the Chronic Kidney Disease Epidemiology Collaboration equation (P < 0.001). CONCLUSIONS: A Deming regression model was chosen to optimally calibrate baseline serum creatinine measurements in the JHS, and the calibrated values provide a lower CKD prevalence estimate.
Authors: Myra A Carpenter; Richard Crow; Michael Steffes; William Rock; Jeffrey Heilbraun; Gregory Evans; Thomas Skelton; Robert Jensen; Daniel Sarpong Journal: Am J Med Sci Date: 2004-09 Impact factor: 2.378
Authors: Daron R Stevens; Carlos Flores-Mir; Brian Nebbe; Donald W Raboud; Giseon Heo; Paul W Major Journal: Am J Orthod Dentofacial Orthop Date: 2006-06 Impact factor: 2.650
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: John B Eastwood; Sally M Kerry; Jacob Plange-Rhule; Frank B Micah; Sampson Antwi; Frances G Boa; Debasish Banerjee; Lynsey Emmett; Michelle A Miller; Francesco P Cappuccio Journal: Nephrol Dial Transplant Date: 2010-01-25 Impact factor: 5.992
Authors: Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey Journal: JAMA Date: 2012-05-09 Impact factor: 56.272
Authors: Leila R Zelnick; Ronit Katz; Bessie A Young; Adolfo Correa; Bryan R Kestenbaum; Ian H de Boer; Nisha Bansal Journal: Am J Kidney Dis Date: 2017-01-28 Impact factor: 8.860
Authors: Stanford Mwasongwe; Yan Gao; Michael Griswold; James G Wilson; Abraham Aviv; Alexander P Reiner; Laura M Raffield Journal: Atherosclerosis Date: 2017-09-15 Impact factor: 5.162
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Rita R Kalyani; Hsin-Chieh Yeh; Alain G Bertoni; Valery S Effoe; Ramon Casanova; Mario Sims; Wen-Chih Wu; Gary S Wand; Adolfo Correa; Sherita H Golden Journal: JACC Heart Fail Date: 2017-08-16 Impact factor: 12.035
Authors: Joseph Lunyera; Clemontina A Davenport; Nrupen A Bhavsar; Mario Sims; Julia Scialla; Jane Pendergast; Rasheeda Hall; Crystal C Tyson; Jennifer St Clair Russell; Wei Wang; Adolfo Correa; L Ebony Boulware; Clarissa J Diamantidis Journal: Clin J Am Soc Nephrol Date: 2018-01-03 Impact factor: 8.237
Authors: Casey M Rebholz; Jane L Harman; Morgan E Grams; Adolfo Correa; Daichi Shimbo; Josef Coresh; Bessie A Young Journal: J Am Soc Nephrol Date: 2017-07-11 Impact factor: 10.121
Authors: John N Booth; Marwah Abdalla; Rikki M Tanner; Keith M Diaz; Samantha G Bromfield; Gabriel S Tajeu; Adolfo Correa; Mario Sims; Gbenga Ogedegbe; Adam P Bress; Tanya M Spruill; Daichi Shimbo; Paul Muntner Journal: Hypertension Date: 2017-06-26 Impact factor: 10.190
Authors: Vanessa Grubbs; Eric Vittinghoff; James D Beck; Abhijit V Kshirsagar; Wei Wang; Michael E Griswold; Neil R Powe; Adolfo Correa; Bessie Young Journal: J Periodontol Date: 2015-06-25 Impact factor: 6.993
Authors: Demetria Hubbard; Lisandro D Colantonio; Rikki M Tanner; April P Carson; Swati Sakhuja; Byron C Jaeger; Robert M Carey; Laura P Cohen; Daichi Shimbo; Mark Butler; Alain G Bertoni; Aisha T Langford; John N Booth; Jolaade Kalinowski; Paul Muntner Journal: Diabetes Care Date: 2019-10-07 Impact factor: 19.112
Authors: Zihe Zheng; Jane L Harman; Josef Coresh; Anna Köttgen; Mara A McAdams-DeMarco; Adolfo Correa; Bessie A Young; Ronit Katz; Casey M Rebholz Journal: J Nutr Date: 2018-03-01 Impact factor: 4.798
Authors: Bessie A Young; Ronit Katz; L Ebony Boulware; Bryan Kestenbaum; Ian H de Boer; Wei Wang; Tibor Fülöp; Nisha Bansal; Cassianne Robinson-Cohen; Michael Griswold; Neil R Powe; Jonathan Himmelfarb; Adolfo Correa Journal: Am J Kidney Dis Date: 2016-04-09 Impact factor: 8.860